CN101663022A - 局部药物制剂 - Google Patents

局部药物制剂 Download PDF

Info

Publication number
CN101663022A
CN101663022A CN200880007936A CN200880007936A CN101663022A CN 101663022 A CN101663022 A CN 101663022A CN 200880007936 A CN200880007936 A CN 200880007936A CN 200880007936 A CN200880007936 A CN 200880007936A CN 101663022 A CN101663022 A CN 101663022A
Authority
CN
China
Prior art keywords
compositions
diclofenac
glycol ether
weight
nsaid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880007936A
Other languages
English (en)
Chinese (zh)
Inventor
A·F·戴维斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUTURA MEDICAL DEVELOPMENTS Ltd
Original Assignee
FUTURA MEDICAL DEVELOPMENTS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUTURA MEDICAL DEVELOPMENTS Ltd filed Critical FUTURA MEDICAL DEVELOPMENTS Ltd
Publication of CN101663022A publication Critical patent/CN101663022A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200880007936A 2007-03-13 2008-02-15 局部药物制剂 Pending CN101663022A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0704846.5 2007-03-13
GBGB0704846.5A GB0704846D0 (en) 2007-03-13 2007-03-13 Topical pharmaceutical formulation

Publications (1)

Publication Number Publication Date
CN101663022A true CN101663022A (zh) 2010-03-03

Family

ID=37988913

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880007936A Pending CN101663022A (zh) 2007-03-13 2008-02-15 局部药物制剂

Country Status (21)

Country Link
US (1) US8541470B2 (https=)
EP (2) EP2452671A2 (https=)
JP (1) JP2010521442A (https=)
CN (1) CN101663022A (https=)
AU (1) AU2008224735B2 (https=)
BR (1) BRPI0808887A2 (https=)
CA (1) CA2680074C (https=)
CO (1) CO6220926A2 (https=)
DK (1) DK2131813T3 (https=)
ES (1) ES2391914T3 (https=)
GB (1) GB0704846D0 (https=)
MX (1) MX2009009758A (https=)
MY (1) MY149545A (https=)
NZ (1) NZ579895A (https=)
PL (1) PL2131813T3 (https=)
PT (1) PT2131813E (https=)
RU (1) RU2468794C2 (https=)
SG (1) SG179480A1 (https=)
TW (1) TWI367110B (https=)
UA (1) UA100509C2 (https=)
WO (1) WO2008110741A2 (https=)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104826116A (zh) * 2003-11-20 2015-08-12 诺沃挪第克公司 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
CN104968330A (zh) * 2013-01-14 2015-10-07 因佛斯特医疗有限公司 用于治疗剧痛的组合物及方法
CN107249573A (zh) * 2015-02-20 2017-10-13 富图拉医药发展有限公司 局部药物制剂
US11318191B2 (en) 2020-02-18 2022-05-03 Novo Nordisk A/S GLP-1 compositions and uses thereof
US11752198B2 (en) 2017-08-24 2023-09-12 Novo Nordisk A/S GLP-1 compositions and uses thereof
US11826428B2 (en) 2010-10-29 2023-11-28 Infirst Healthcare Limited Solid solution compositions comprising cannabidiols
US11918654B2 (en) 2010-10-29 2024-03-05 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11992555B2 (en) 2010-10-29 2024-05-28 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105218565A (zh) 2008-10-17 2016-01-06 泽农医药公司 螺羟吲哚化合物及其作为治疗剂的用途
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
MX2012004373A (es) 2009-10-14 2012-06-28 Xenon Pharmaceuticals Inc Metodos sinteticos para compuestos espiro-oxoindol.
CA2788440A1 (en) 2010-02-26 2011-09-01 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
EA201491854A1 (ru) 2012-04-12 2015-03-31 Ксенон Фармасьютикалз Инк. Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств
ES2763352T3 (es) * 2013-01-14 2020-05-28 Infirst Healthcare Ltd Composiciones de solución sólida y uso en inflamación crónica
HK1218621A1 (zh) * 2013-02-04 2017-03-03 Infirst Healthcare Limited 用於治疗慢性炎症和炎性疾病的组合物及方法
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
TW201636017A (zh) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法
FR3041534B1 (fr) 2015-09-30 2019-03-15 Vetoquinol Sa Composition de nettoyant auriculaire
GB201609968D0 (en) * 2016-06-07 2016-07-20 Futura Medical Dev Ltd Topical pharmaceutical formulation
US10100060B2 (en) 2016-06-16 2018-10-16 Xenon Pharmaceuticals Inc. Asymmetric synthesis of funapide
JP7250689B2 (ja) * 2017-03-07 2023-04-03 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド 活性化合物のための局所送達系
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface
GB2596286B (en) 2020-06-20 2023-01-25 Francis Davis Adrian Adherence to topical therapy
GB2597526A (en) 2020-07-27 2022-02-02 Incanthera R&D Ltd Topical formulation
CN116348099B (zh) 2020-07-27 2025-10-31 英加世瑞(研发)有限公司 局部用制剂
GB202012836D0 (en) 2020-08-17 2020-09-30 Futura Medical Developments Ltd Topical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤
PE20011092A1 (es) * 2000-02-14 2001-11-12 Procter & Gamble Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
PE20040321A1 (es) * 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
WO2005027977A2 (en) * 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Diclofenac compositions for the treatment of skin disorders
EP1588697A1 (en) 2004-04-16 2005-10-26 Kurt H. Prof. Dr. Bauer Emulsion gel for topical application of pharmaceuticals
US20050244522A1 (en) 2004-04-30 2005-11-03 Carrara Dario Norberto R Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104826116A (zh) * 2003-11-20 2015-08-12 诺沃挪第克公司 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
US11826428B2 (en) 2010-10-29 2023-11-28 Infirst Healthcare Limited Solid solution compositions comprising cannabidiols
US11918654B2 (en) 2010-10-29 2024-03-05 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11992555B2 (en) 2010-10-29 2024-05-28 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
CN104968330A (zh) * 2013-01-14 2015-10-07 因佛斯特医疗有限公司 用于治疗剧痛的组合物及方法
CN107249573A (zh) * 2015-02-20 2017-10-13 富图拉医药发展有限公司 局部药物制剂
US11752198B2 (en) 2017-08-24 2023-09-12 Novo Nordisk A/S GLP-1 compositions and uses thereof
US12214017B2 (en) 2017-08-24 2025-02-04 Novo Nordisk A/S GLP-1 compositions and uses thereof
US11318191B2 (en) 2020-02-18 2022-05-03 Novo Nordisk A/S GLP-1 compositions and uses thereof

Also Published As

Publication number Publication date
WO2008110741A2 (en) 2008-09-18
CA2680074C (en) 2016-07-12
GB0704846D0 (en) 2007-04-18
NZ579895A (en) 2012-02-24
DK2131813T3 (da) 2012-10-29
EP2131813A2 (en) 2009-12-16
RU2468794C2 (ru) 2012-12-10
UA100509C2 (ru) 2013-01-10
AU2008224735B2 (en) 2013-04-18
AU2008224735A1 (en) 2008-09-18
EP2452671A2 (en) 2012-05-16
US8541470B2 (en) 2013-09-24
CA2680074A1 (en) 2008-09-18
SG179480A1 (en) 2012-04-27
BRPI0808887A2 (pt) 2014-09-02
WO2008110741A3 (en) 2009-03-12
US20100099767A1 (en) 2010-04-22
TW200836769A (en) 2008-09-16
TWI367110B (en) 2012-07-01
PT2131813E (pt) 2012-10-31
WO2008110741A8 (en) 2009-11-19
ES2391914T3 (es) 2012-12-03
RU2009136228A (ru) 2011-04-20
MX2009009758A (es) 2009-09-24
EP2131813B1 (en) 2012-08-08
CO6220926A2 (es) 2010-11-19
JP2010521442A (ja) 2010-06-24
MY149545A (en) 2013-09-13
PL2131813T3 (pl) 2012-11-30

Similar Documents

Publication Publication Date Title
CN101663022A (zh) 局部药物制剂
US20050158348A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
JP4549006B2 (ja) ゲル軟膏
CN106572970B (zh) 用于局部给药非甾体抗炎药以缓解肌肉骨骼疼痛的新型凝胶及其制备方法
JP5052558B2 (ja) ゲル軟膏
PT503988E (pt) Composicoes para o tratamento de onicomicoses
WO2011070318A2 (en) Topical formulation
CN106604717A (zh) 局部用双氯芬酸钠组合物
US10028927B2 (en) Topical pharmaceutical formulation
JP4195178B2 (ja) 消炎鎮痛外用剤
ES2880437T3 (es) Nuevas composiciones tópicas que comprenden ácido úsnico y su uso terapéutico
CN115379824A (zh) 用于局部递送活性剂的溶剂递送系统
CA2500907A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
US11376213B2 (en) Topical pharmaceutical formulation
HK1140954A (zh) 局部药物制剂
BR112021008677A2 (pt) composições farmacêuticas tópicas de teriflunomida, processo de preparação e uso
EP3218060B1 (en) Sprayable analgesic compositions
HK1170676A (en) Topical pharmaceutical formulation
JP5565995B2 (ja) 鎮痒剤
TR2024002454A1 (tr) Topical compositions comprising nimesulide and diclofenac sodium and a salicylate
KR20150131594A (ko) 항진균 의약 조성물

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1140954

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100303

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1140954

Country of ref document: HK